ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FULC Fulcrum Therapeutics Inc

3.30
0.09 (2.80%)
Last Updated: 17:35:18
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.88M1.18M685k295k1.18M871k080M
Operating Income -34.24M-24.36M-27.97M-27.94M-55.23M-27.99M-29.83M52.49M
Pre Tax Income -34.07M-23.74M-26.14M-24.78M-48.56M-24.76M-26.87M55.41M
Net Income -34.07M-23.74M-26.14M-24.78M-48.56M-24.76M-26.87M55.41M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -34.24M-24.36M-25.28M-24.78M-48.56M-24.76M-26.87M55.41M
EBITDA -33.56M-23.74M-27.38M-27.37M-54.1M-27.48M-29.36M52.87M
Year End 31 December 2023 2017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0008.82M19.16M6.34M2.81M
Operating Income -22.99M-33.5M-84.22M-71.61M-81.05M-112.56M-110.66M
Pre Tax Income -22.96M-32.59M-82.68M-70.82M-80.85M-109.87M-97.34M
Net Income -25.37M-39.15M-89.81M-70.82M-80.85M-109.87M-97.34M
Preferred Dividends -2.41M-6.56M-7.13M0000
Basic Earnings Per Share (EPS) -3.728-3.522-3.964-2.535-1.99-2.704-1.574
EBIT -22.97M-33.11M-84.19M-71.61M-80.85M-109.87M-97.34M
EBITDA -22.28M-32.15M-82.16M-69.23M-78.54M-110.15M-108.49M